Drugs for Neglected Diseases initiative
@DNDi
International non-profit developing safe, effective, and affordable treatments for the most neglected patients. #BestScienceforAll
ID:256440168
https://dndi.org 23-02-2011 09:59:25
11,5K Tweets
24,2K Followers
3,0K Following
Follow People
Prof Sam Kariuki, BVM, MSc, PhD, DSc (Hons, LSTM)
@DNDi Eastern Africa Director. Passionate about research in tropical medicine, especially infectious diseases, neglected diseases and antimicrobial resistance.
Africa CDC
@AfricaCDC is a continental autonomous health agency of the @_AfricanUnion strengthening the capacity of MS to respond quickly & effectively to disease threats.
Uniting to Combat Neglected Tropical Diseases
Our partnership works to control, eliminate, and eradicate neglected tropical diseases & improve the lives of over a billion people
Unlimit Health (formerly SCI Foundation)
We work with affected countries, sharing evidence and expertise to end parasitic disease and to support people to live healthy lives, free from limiting disease
𝔻𝕣. 𝔸𝕙𝕞𝕖𝕕 𝕆𝕘𝕨𝕖𝕝l - FAPH
𝙂𝙡𝙤𝙗𝙖𝙡 𝙃𝙚𝙖𝙡𝙩𝙝 | 𝙃𝙚𝙖𝙡𝙩𝙝 𝙎𝙚𝙘𝙪𝙧𝙞𝙩𝙮 | 𝙋𝙪𝙗𝙡𝙞𝙘 𝙃𝙚𝙖𝙡𝙩𝙝 𝙇𝙚𝙖𝙙𝙚𝙧𝙨𝙝𝙞𝙥 | Former Deputy DG at Africa CDC
📖 Friday read: Our Scientific Affairs Senior Manager Shikha Taneja Malik talks to WomenLift Health about raising awareness of cervical cancer in India 🇮🇳 and the importance of the HPV vaccine ⬇️
womenlifthealth.org/article/qa-wit…
We connected with @DrZul, Minister of Health KKMalaysia🇲🇾🩺❤️, and other key figures at our booth during #CRMTrialConnect2024 in KL, Malaysia 🇲🇾 yesterday. We discussed our work in #hepatitisC and #dengue , and our commitment to innovation in healthcare.
Introducing Interim Director of Drugs for Neglected Diseases initiative SEA, Ms. Vanessa Daniel to Dzulkefly Ahmad, Minister of Health, KKMalaysia🇲🇾🩺❤️ - who visited our booth at CRM Trial Connect Conference 2024, while speaking of DNDi's work and journey so far, in the presence of Dr. Akhmal Yusof, CEO Clinical Research MY
Fantastic overview just out in infobae on our Chagas Platform meeting going on today in Buenos Aires, Argentina (in Spanish). Thank you to Mundo Sano, ASAPECHAVAE ONGD. and others for speaking out. infobae.com/salud/2024/05/…
Dr. Maria Elena Bottazzi presents the progress made in the development of the next #Chagas #vaccine in the XI Reunión Plenaria de la Plataforma #Chagas . BCMHouston Prof Peter Hotez MD PhD BCM_TropMed
Day 2 of the Chagas Platform meeting in Buenos Aires! Our Head of Chagas Disease Maria-Jesus Pinazo with the President of the International Federation of Chagas Patients Elvira Idalia Hernández. Patients involved at every step of R&D for #Chagas Coalición Chagas
[Press Release📢]
GHIT announced today a total investment of approximately JPY 1.64B(USD 10.8M) in four projects for the development of new drugs for #malaria and #NTDs .
Press Release👉ghitfund.org/newsroom/press…
#Onchocerciasis #LymphaticFilariasis #Chagas
![[Press Release📢] GHIT announced today a total investment of approximately JPY 1.64B(USD 10.8M) in four projects for the development of new drugs for #malaria and #NTDs . Press Release👉ghitfund.org/newsroom/press… #Onchocerciasis #LymphaticFilariasis #Chagas](https://pbs.twimg.com/media/GNCXOnObkAAUFKr.jpg "GHIT Fund (グローバルヘルス技術振興基金) (@GHITFund) on Twitter photo 2024-05-09 03:00:00 [Press Release📢] GHIT announced today a total investment of approximately JPY 1.64B(USD 10.8M) in four projects for the development of new drugs for #malaria and #NTDs . Press Release👉ghitfund.org/newsroom/press… #Onchocerciasis #LymphaticFilariasis #Chagas")
The Chagas Platform meeting is happening this week in Buenos Aires! Researchers, doctors, academics, patients - all united to find better treatment solutions for this silent killer Maria-Jesus Pinazo Sergio Sosa-Estani Follow Mundo Sano Coalición Chagas for updates! #chagas
Did you know there are many species of parasitic worm infection – and there’s hope one drug could be effective against several? #eWhormFacts
We're progressing the pharmaceutical development of oxfendazole & evaluating its use for helminth infections.
🔸 ewhorm.org/who-we-are/par…
New in ACS Publications: Learn about two practical, cost-effective methods to synthesize the crucial intermediate for a potential visceral #leishmaniasis drug DNDI-6148.
📖 pubs.acs.org/doi/10.1021/ac…
#Mycetoma is a chronic, progressively destructive infectious disease.
The world's first clinical trial against mycetoma, developed by Eisai Global Drugs for Neglected Diseases initiative supported by GHIT, demonstrated that fosravuconazole is safe, patient-friendly &effective for treatment.
youtu.be/zRCYMLTSr5A
We're grateful to Gates Foundation for their long-term financial support. Read in The Lancet Infectious Diseases how sustained investment has supported R&D for diseases including #sleepingsickness and #riverblindness :
📖 thelancet.com/issue/S1473-30…
Missed our recent webinar on #AI ’s role in bringing safe and effective treatments for #NTDs ?
Watch the full 'AI in Drug Discovery' session, with expert insights from IIT Hyderabad Jawaharlal Nehru University (JNU) IIIT Delhi and our Discovery Director Charles Mowbray ⬇️
bit.ly/DNDi-AI-Drug-D…
A new opportunity at Drugs for Neglected Diseases initiative South Asia!
If you are passionate about equitable access to healthcare and have a keen sense of initiative to spot fundraising opportunities for medical R&D and global health, apply now to be our External Relations Manager!
t.ly/eb2Sn
Congratulations to #noma campaigners Mulikat Okanlawon and Fidel Strub - named in TIME's 100 influential people in global health! TIMEHealth #TIME100HEALTH
Their awareness-raising contributed to World Health Organization (WHO) adding noma to its list of #NTDs 🙌 Elysium Noma Survivors Association
📰 time.com/6967236/okanla…
